佰金生命科学(01466)拟折让约14.29%发行4000万股认购股份 净筹约1910万港元

Group 1 - The company, Baijin Life Sciences (01466), announced a subscription agreement to issue a total of 40 million shares at a subscription price of HKD 0.48 per share [1] - The subscription price represents a discount of approximately 14.29% compared to the closing price of HKD 0.56 per share on the date of the agreement [1] - The net proceeds from the subscription are approximately HKD 19.1 million, which will be used for the company's general working capital [1]